{"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2023-04-19", "Rating": [{"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$289 to $310"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$300 to $325"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$285 to $315"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$305 to $309"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$270 to $323"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$265 to $285"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$250 to $335"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": "$240 to $270"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$305 to $317"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "BTIG Research", "Rating_Change": "Buy", "Target_Change": "$284 to $313"}, {"Date": "2023-04-19", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$300 to $315"}, {"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$278"}, {"Date": "2023-03-23", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$235"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$215"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$210"}, {"Date": "2022-04-13", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$360"}, {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$315"}, {"Date": "2022-03-25", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$340"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$340"}, {"Date": "2022-02-02", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$317 to $325"}, {"Date": "2022-01-31", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$300 to $310"}, {"Date": "2022-01-25", "Rating": "Downgrade", "Organization": "Redburn", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-01-21", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$370 to $360"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$381 to $350"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$338 to $317"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$370 to $325"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$370 to $315"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$383 to $334"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$330 to $300"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$375 to $325"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": "$340 to $290"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$323 to $300"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "BTIG Research", "Rating_Change": "Buy", "Target_Change": "$372 to $360"}, {"Date": "2022-01-10", "Rating": "Upgrade", "Organization": "BTIG Research", "Rating_Change": "Neutral to Buy", "Target_Change": "$372"}, {"Date": "2021-10-01", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$1100"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$916 to $1060"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$890 to $970"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": "$930 to $975"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$1060 to $1100"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$840 to $970"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$855 to $930"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$900 to $1000"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$939 to $1100"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$890 to $1020"}, {"Date": "2021-07-14", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$953 to $1090"}, {"Date": "2021-06-01", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "Underperform to In-line", "Target_Change": ""}, {"Date": "2021-04-21", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$825 to $925"}, {"Date": "2021-04-21", "Rating": "Upgrade", "Organization": "Oppenheimer", "Rating_Change": "Underperform to Perform", "Target_Change": ""}, {"Date": "2021-04-01", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$862"}, {"Date": "2020-12-15", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$780"}, {"Date": "2020-09-28", "Rating": "Initiated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$775"}, {"Date": "2020-09-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$789"}, {"Date": "2020-09-08", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$725 to $760"}, {"Date": "2020-09-02", "Rating": "Initiated", "Organization": "Robert W. Baird", "Rating_Change": "Neutral", "Target_Change": "$700"}]}